{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:44:15Z","timestamp":1787496255816,"version":"build-2736575974"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.rgmxen.2023.07.007","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T09:33:32Z","timestamp":1710322412000},"page":"340-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of prognostic factors for survival in patients with metastatic gastric adenocarcinoma in a Mexican population"],"prefix":"10.1016","volume":"89","author":[{"given":"A.M.","family":"Le\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.B.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.S.","family":"Lino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A","family":"Salcedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmxen.2023.07.007_bib0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.rgmxen.2023.07.007_bib0010","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.3390\/jcm11154337","article-title":"Gastric cancer screening in Japan: a narrative review","volume":"11","author":"Yashima","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.rgmxen.2023.07.007_bib0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/annonc\/mdw350","article-title":"Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Smyth","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.rgmxen.2023.07.007_bib0020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12876-018-0877-9","article-title":"Low lymphocyte count and high monocyte count predicts poor prognosis of gastric cancer","volume":"18","author":"Feng","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.rgmxen.2023.07.007_bib0025","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.21873\/anticanres.13381","article-title":"Neutrophil-to-lymphocyte ratio as a prognostic indicator in patients with unresectable gastric cancer","volume":"39","author":"Murakami","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.rgmxen.2023.07.007_bib0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12957-015-0530-9","article-title":"Meta-analysis of associations between neutrophil-to-lymphocyte ratio and prognosis of gastric cancer","volume":"13","author":"Chen","year":"2015","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.rgmxen.2023.07.007_bib0035","first-page":"2131","article-title":"Dynamic perspective of the neutrophil-to-lymphocyte ratio in metastatic gastric cancer","volume":"26","author":"Castineiras","year":"2021","journal-title":"J BUON"},{"key":"10.1016\/j.rgmxen.2023.07.007_bib0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12957-020-01952-2","article-title":"Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta- analysis","volume":"18","author":"Zhang","year":"2020","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.rgmxen.2023.07.007_bib0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/theoncologist.9-90005-10","article-title":"The role of hypoxia-induced factors in tumor progression","volume":"9","author":"Vaupel","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.rgmxen.2023.07.007_bib0050","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.clnu.2018.02.015","article-title":"Prognostic significance of perioperative nutritional parameters in patients with gastric cancer","volume":"38","author":"Oh","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.rgmxen.2023.07.007_bib0055","doi-asserted-by":"crossref","first-page":"17638","DOI":"10.18632\/aging.203256","article-title":"Pretreatment neutrophil-to-lymphocyte ratio predicts the benefit of gastric cancer patients with systemic therapy","volume":"13","author":"Du","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.rgmxen.2023.07.007_bib0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40880-016-0122-2","article-title":"Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer","volume":"35","author":"Sun","year":"2016","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.rgmxen.2023.07.007_bib0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12876-020-1167-x","article-title":"The prognostic role of platelet-to-lymphocyte ratio on overall survival in gastric cancer: a systematic review and meta-analysis","volume":"20","author":"Cao","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.rgmxen.2023.07.007_bib0070","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jso.20272","article-title":"Pretreatment anemia is associated with poorer survival in patients with stage I and II gastric cancer","volume":"91","author":"Shen","year":"2005","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.rgmxen.2023.07.007_bib0075","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.655716","article-title":"The prognostic value of pre-treatment hemoglobin (Hb) in patients with advanced or metastatic gastric cancer treated with immunotherapy","volume":"11","author":"Gou","year":"2021","journal-title":"Front Oncol"}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X24000057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X24000057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T11:21:38Z","timestamp":1723548098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2255534X24000057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2255534X24000057"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmxen.2023.07.007","relation":{},"ISSN":["2255-534X"],"issn-type":[{"value":"2255-534X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of prognostic factors for survival in patients with metastatic gastric adenocarcinoma in a Mexican population","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmxen.2023.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2023.07.008","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}